Artificial intelligence spots hidden liver scarring from simple blood tests
NCT ID NCT07675525
First seen Jun 30, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests a computer program called NIMIT-AI that analyzes routine blood test results over multiple doctor visits to detect liver scarring in people with fatty liver disease (MASLD). Unlike the current standard method (FIB-4), which often misses cases and fails with incomplete data, NIMIT-AI uses deep learning to spot patterns suggesting fibrosis. The tool was developed using health records from 969 patients at a Thai hospital and showed better accuracy than FIB-4, even when some lab results were missing. No extra tests or procedures were required from patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NIMIT-AI (artificial intelligence diagnostic model)
What this could lead to
If successful, this AI tool could help doctors catch liver scarring earlier in fatty liver disease patients, potentially preventing progression to severe liver damage.
What could go wrong
This is a retrospective study using data from one hospital in Thailand, so results may not apply to other populations. The AI needs prospective validation before clinical use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MASLD (METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Faculty of Medicine Siriraj Hospital
Bangkok Noi, Bangkok, 10700, Thailand